JD Health, a spin off from the chinese e-commerce giant JD.com, is a marketplace that sells platform for pharmaceutical products such as vitamins & supplements, medical supplies, contact lenses, adult products, traditional medicine, and more.
JD Health aims to set a new standard for telemedicine services across China by providing whole families with remote access to doctors.
JD Health was formed in May 2019. The company has its headquartered in based in Beijing, Beijing, China.
JD Health began as an e-commerce platform for selling products such as vitamins, supplements, medical devices, and contact lenses, as well as offering services including health checks, beauty clinics, and gene testing in partnership with specialized institutions. The business also taps into the wholesale drugs market and web-based hospital services.
JD Health's online hospitals offer online-to-offline (O2O) treatment through a partnership with medical institutions. The doctors on the platform come from 327 cities in 32 provincial-level administrative regions.
JD Health operates the largest online retail pharmacy in China with a fast-growing online healthcare services platform, could list as early as the fourth quarter of the year and raise up to US$1bn in Hong Kong.
JD Health is backed by JD Inc., Hillhouse Capital, CPEChina Fund, CICC Capital, Baring Private Equity Asia. The company raised a record breaking $3.5B after pricing Asia's biggest healthcare IPO offering on Dec 01, 2020. This brings the total amount raised by JD Health to $5.33B to date. The IPO valued JD Health at nearly $29B.